2025-08-08 |
13G
|
IMUX / Immunic, Inc.
|
|
|
10,634,446 |
|
|
|
2025-02-14 |
13G/A
|
AFMDQ / Affimed N.V.
|
|
924,600 |
654,600 |
|
|
|
2025-02-14 |
13G/A
|
INSE / Inspired Entertainment, Inc.
|
|
1,825,000 |
1,700,000 |
|
|
|
2025-02-14 |
13G/A
|
MODD / Modular Medical, Inc.
|
|
2,211,999 |
2,241,999 |
|
|
|
2024-11-15 |
13G/A
|
CCTS / Cactus Acquisition Corp. 1 Limited
|
|
450,000 |
0 |
|
|
|
2024-10-24 |
13G
|
AFMDQ / Affimed N.V.
|
|
7,106,250 |
924,600 |
|
|
|
2024-06-24 |
13G
|
PCSC / Perceptive Capital Solutions Corp
|
|
|
500,000 |
|
|
|
2024-03-01 |
13G
|
MODD / Modular Medical, Inc.
|
|
|
2,211,999 |
|
|
|
2024-02-14 |
13G/A
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
3,115,000 |
70,000 |
|
|
|
2024-02-14 |
13G/A
|
RKTA.U / Rocket Internet Growth Opportunities Corp. Units, each consisting of one Class A ordinary share and
|
|
1,490,000 |
0 |
|
|
|
2024-02-14 |
13G/A
|
CNDA / Concord Acquisition Corp II
|
|
2,475,000 |
0 |
|
|
|
2024-02-14 |
13G/A
|
CDLX / Cardlytics, Inc.
|
|
1,883,020 |
1,758,462 |
|
|
|
2024-02-14 |
13G/A
|
LITT / Logistics Innovation Technologies Corp - Class A
|
|
1,994,267 |
0 |
|
|
|
2024-02-14 |
13G/A
|
ORIAU / Orion Biotech Opportunities Corp - Units (1 Ord Share Class A & 1/5 War)
|
|
1,200,000 |
0 |
|
|
|
2024-02-14 |
13G/A
|
KYG3934N1236 / Global Technology Acquisition Corp. I
|
|
|
0 |
|
|
|
2024-02-14 |
13G/A
|
TIOAU / Tio Tech A - Units (1 Ord Share Class A & 1/3 War)
|
|
2,000,000 |
0 |
|
|
|
2024-02-14 |
13G/A
|
INSE / Inspired Entertainment, Inc.
|
|
2,100,000 |
1,825,000 |
|
|
|
2024-02-14 |
13G/A
|
FLAG.U / First Light Acquisition Group, Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
|
|
300,000 |
675,758 |
|
|
|
2024-02-14 |
13G/A
|
WVE / Wave Life Sciences Ltd.
|
|
6,000,000 |
5,600,000 |
|
|
|
2024-02-14 |
13G/A
|
KYG2542B1095 / Counter Press Acquisition Corp.
|
|
745,000 |
0 |
|
|
|
2024-02-14 |
13G
|
CCTS / Cactus Acquisition Corp. 1 Limited
|
|
|
450,000 |
|
|
|
2024-02-14 |
13G/A
|
ARYE / ARYA Sciences Acquisition Corp V - Class A
|
|
1,000,000 |
0 |
|
|
|
2024-02-14 |
13G/A
|
ENVA / Enova International, Inc.
|
|
2,510,000 |
580,000 |
|
|
|
2024-02-14 |
13G/A
|
/ Crixus BH3 Acquisition Co., Class A
|
|
1,980,000 |
0 |
|
|
|
2024-02-14 |
13G/A
|
CNDB.U / Concord Acquisition Corp III U Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
|
|
2,475,000 |
134,938 |
|
|
|
2024-02-14 |
13G/A
|
IRS / IRSA Inversiones y Representaciones Sociedad Anónima - Depositary Receipt (Common Stock)
|
|
45,400,400 |
26,115,110 |
|
|
|
2024-02-14 |
13G/A
|
TCOA.U / Trajectory Alpha Acquisition C Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant
|
|
1,484,799 |
0 |
|
|
|
2024-02-14 |
13G/A
|
PANA / Panacea Acquisition Corp II - Class A
|
|
1,480,000 |
0 |
|
|
|
2024-02-14 |
13G/A
|
SBNY / Signature Bank
|
|
3,782,322 |
958,036 |
|
|
|
2024-02-13 |
13G/A
|
AFMD / Affimed N.V.
|
|
9,106,250 |
7,106,250 |
|
|
|
2023-05-30 |
13G
|
SBNY / Signature Bank
|
|
|
3,782,322 |
|
|
|
2023-02-15 |
13G/A
|
CDLX / Cardlytics, Inc.
|
|
2,176,659 |
1,883,020 |
|
|
|
2023-02-14 |
13G/A
|
TCOA.U / Trajectory Alpha Acquisition C Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant
|
|
1,578,750 |
1,484,799 |
|
|
|
2023-02-14 |
13G/A
|
IRS / IRSA Inversiones y Representaciones Sociedad Anónima - Depositary Receipt (Common Stock)
|
|
36,043,990 |
45,400,400 |
|
|
|
2023-02-14 |
13G/A
|
ARYE / ARYA Sciences Acquisition Corp V - Class A
|
|
900,000 |
1,000,000 |
|
|
|
2023-02-14 |
13G/A
|
US6710052050 / OPY Acquisition Corp. I
|
|
750,000 |
231,500 |
|
|
|
2023-02-14 |
13G/A
|
MRNS / Marinus Pharmaceuticals, Inc.
|
|
1,932,829 |
90,000 |
|
|
|
2023-02-14 |
13G/A
|
RKTA.U / Rocket Internet Growth Opportunities Corp. Units, each consisting of one Class A ordinary share and
|
|
1,500,000 |
1,490,000 |
|
|
|
2023-02-14 |
13G/A
|
DRTTF / DIRTT Environmental Solutions Ltd.
|
|
6,430,108 |
218,490 |
|
|
|
2023-02-14 |
13G/A
|
LITT / Logistics Innovation Technologies Corp - Class A
|
|
2,000,000 |
1,994,267 |
|
|
|
2023-02-14 |
13G/A
|
/ Crixus BH3 Acquisition Co.
|
|
|
500,000 |
|
|
|
2023-02-14 |
13G/A
|
INSE / Inspired Entertainment, Inc.
|
|
2,030,770 |
2,100,000 |
|
|
|
2023-02-14 |
13G/A
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
3,300,000 |
3,115,000 |
|
|
|
2023-02-14 |
13G/A
|
SQZB / SQZ Biotechnologies Company
|
|
1,852,135 |
1,330,889 |
|
|
|
2023-02-14 |
13G/A
|
HWKZ.U / Hawks Acquisition Corp Units, Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant
|
|
1,980,000 |
1,979,592 |
|
|
|
2023-02-14 |
13G/A
|
ENVA / Enova International, Inc.
|
|
3,049,000 |
2,510,000 |
|
|
|
2023-02-14 |
13G/A
|
WVE / Wave Life Sciences Ltd.
|
|
3,630,425 |
6,000,000 |
|
|
|
2023-02-14 |
13G/A
|
AFMD / Affimed N.V.
|
|
6,246,250 |
9,106,250 |
|
|
|
2023-02-14 |
13G/A
|
US05467C1080 / AxonPrime Infrastructure Acquisition Corp., Class A
|
|
1,000,000 |
441,138 |
|
|
|
2023-02-14 |
13G/A
|
FLAG.U / First Light Acquisition Group, Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
|
|
1,200,000 |
300,000 |
|
|
|
2022-09-26 |
13G
|
CND / Concord Acquisition Corp - Class A
|
|
250,000 |
1,550,649 |
|
|
|
2022-07-21 |
13G
|
CDLX / Cardlytics, Inc.
|
|
|
2,176,659 |
|
|
|
2022-05-26 |
13G
|
WVE / Wave Life Sciences Ltd.
|
|
|
3,630,425 |
|
|
|
2022-02-22 |
13G
|
KYG2542B1095 / Counter Press Acquisition Corp.
|
|
|
745,000 |
|
|
|
2022-02-14 |
13G/A
|
ACHR / Archer Aviation Inc.
|
|
3,182,730 |
0 |
|
|
|
2022-02-14 |
13G/A
|
/ Reinvent Technology Partners LLC
|
|
|
0 |
|
|
|
2022-02-14 |
13G/A
|
US90117G1058 / TWC Tech Holdings II Corp
|
|
3,697,636 |
0 |
|
|
|
2022-02-14 |
13G/A
|
HIPO / Hippo Holdings Inc.
|
|
2,200,000 |
0 |
|
|
|
2022-02-14 |
13G/A
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
2,683,600 |
3,300,000 |
|
|
|
2022-02-14 |
13G/A
|
TWND / Tailwind Acquisition Corp - Class A
|
|
2,184,989 |
3,000,000 |
|
|
|
2022-02-14 |
13G/A
|
TPGS / Vacasa Inc - Class A
|
|
1,845,429 |
0 |
|
|
|
2022-02-14 |
13G/A
|
INSE / Inspired Entertainment, Inc.
|
|
2,163,126 |
2,030,770 |
|
|
|
2022-02-14 |
13G/A
|
CND / Concord Acquisition Corp - Class A
|
|
2,500,000 |
250,000 |
|
|
|
2022-02-14 |
13G/A
|
MRNS / Marinus Pharmaceuticals, Inc.
|
|
1,821,149 |
1,932,829 |
|
|
|
2022-02-14 |
13G/A
|
PANA / Panacea Acquisition Corp II - Class A
|
|
1,400,000 |
1,480,000 |
|
|
|
2022-02-14 |
13G/A
|
SQZ / SQZ Biotechnologies Co
|
|
1,578,086 |
1,852,135 |
|
|
|
2022-02-14 |
13G/A
|
/ Khosla Ventures Acquisition Co. II Class A
|
|
|
0 |
|
|
|
2022-02-14 |
13G/A
|
US7786731031 / Roth Ch Acquisition II Co.
|
|
936,624 |
0 |
|
|
|
2022-02-14 |
13G/A
|
MNTS / Momentus Inc.
|
|
962,892 |
0 |
|
|
|
2022-02-14 |
13G/A
|
MHY621511085 / Navios Maritime Containers L.P. Common Units
|
|
0 |
0 |
|
|
|
2022-02-14 |
13G/A
|
QELL / Qell Acquisition Corp - Class A
|
|
2,960,000 |
0 |
|
|
|
2022-02-14 |
13G/A
|
SDC / Smiledirectclub Inc - Class A
|
|
6,276,855 |
276,855 |
|
|
|
2022-02-14 |
13G/A
|
DRT / DIRTT Environmental Solutions Ltd.
|
|
7,465,024 |
6,430,108 |
|
|
|
2022-02-07 |
13G
|
AFMD / Affimed N.V.
|
|
|
6,246,250 |
|
|
|
2021-12-20 |
13G
|
TCOA.U / Trajectory Alpha Acquisition C Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant
|
|
|
1,578,750 |
|
|
|
2021-11-17 |
13G
|
CNDB.U / Concord Acquisition Corp III U Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
|
|
|
2,475,000 |
|
|
|
2021-11-08 |
13G
|
US6710052050 / OPY Acquisition Corp. I
|
|
|
750,000 |
|
|
|
2021-11-01 |
13G
|
GTAC / Global Technology Acquisition Corp. I
|
|
|
1,535,000 |
|
|
|
2021-10-26 |
13G
|
CNDA / Concord Acquisition Corp II
|
|
|
2,475,000 |
|
|
|
2021-10-26 |
13G
|
US05467C1080 / AxonPrime Infrastructure Acquisition Corp., Class A
|
|
|
1,000,000 |
|
|
|
2021-10-26 |
13G
|
FLAG.U / First Light Acquisition Group, Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
|
|
|
1,200,000 |
|
|
|
2021-10-26 |
13G
|
/ Crixus BH3 Acquisition Co., Class A
|
|
|
1,980,000 |
|
|
|
2021-10-22 |
13G
|
KYG385371177 / Gesher I Acquisition Corp
|
|
|
900,000 |
|
|
|
2021-10-22 |
13G
|
HWKZ.U / Hawks Acquisition Corp Units, Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant
|
|
|
1,980,000 |
|
|
|
2021-10-18 |
13G
|
SNII.U / Supernova Partners Acquisition Company II, Ltd. Units, each consisting of one Class A ordinary share
|
|
|
2,200,000 |
|
|
|
2021-08-30 |
13G
|
SDC / Smiledirectclub Inc - Class A
|
|
|
6,276,855 |
|
|
|
2021-08-27 |
13G
|
TPGS / Vacasa Inc - Class A
|
|
|
1,845,429 |
|
|
|
2021-08-20 |
13G
|
IRS / IRSA Inversiones y Representaciones Sociedad Anónima - Depositary Receipt (Common Stock)
|
|
|
36,043,990 |
|
|
|
2021-08-09 |
13G
|
SQZ / SQZ Biotechnologies Co
|
|
|
1,578,086 |
|
|
|
2021-07-23 |
13G
|
ARYE / ARYA Sciences Acquisition Corp V - Class A
|
|
|
900,000 |
|
|
|
2021-07-16 |
13G
|
CND / Concord Acquisition Corp - Class A
|
|
|
2,500,000 |
|
|
|
2021-07-16 |
13G
|
/ Khosla Ventures Acquisition Co. II Class A
|
|
|
4,100,000 |
|
|
|
2021-06-29 |
13G
|
LITT / Logistics Innovation Technologies Corp - Class A
|
|
|
2,000,000 |
|
|
|
2021-06-29 |
13G
|
ORIAU / Orion Biotech Opportunities Corp - Units (1 Ord Share Class A & 1/5 War)
|
|
|
1,200,000 |
|
|
|
2021-04-26 |
13G
|
US7786731031 / Roth Ch Acquisition II Co.
|
|
|
936,624 |
|
|
|
2021-04-19 |
13G
|
TIOAU / Tio Tech A - Units (1 Ord Share Class A & 1/3 War)
|
|
|
2,000,000 |
|
|
|
2021-04-19 |
13G
|
TIOAU / Tio Tech A - Units (1 Ord Share Class A & 1/3 War)
|
|
|
2,000,000 |
|
|
|
2021-04-19 |
13G
|
US90117G1058 / TWC Tech Holdings II Corp
|
|
|
3,697,636 |
|
|
|
2021-04-19 |
13G
|
PANA / Panacea Acquisition Corp II - Class A
|
|
|
1,400,000 |
|
|
|
2021-04-15 |
13G
|
QELL / Qell Acquisition Corp - Class A
|
|
|
2,960,000 |
|
|
|
2021-04-15 |
13G
|
/ Reinvent Technology Partners LLC
|
|
|
4,307,183 |
|
|
|
2021-04-12 |
13G
|
MBTCU / Nocturne Acquisition Corp - Units (1 Ordinary Shares & 1 Rights)
|
|
|
950,000 |
|
|
|
2021-04-05 |
13G
|
HIPO / Hippo Holdings Inc.
|
|
|
2,200,000 |
|
|
|
2021-04-05 |
13G
|
ACHR / Archer Aviation Inc.
|
|
|
3,182,730 |
|
|
|
2021-04-02 |
13G
|
RKTA.U / Rocket Internet Growth Opportunities Corp. Units, each consisting of one Class A ordinary share and
|
|
|
1,500,000 |
|
|
|
2021-03-22 |
13G
|
TWND / Tailwind Acquisition Corp - Class A
|
|
|
2,184,989 |
|
|
|
2021-02-16 |
13G/A
|
TCON / TRACON Pharmaceuticals, Inc.
|
|
258,893 |
198,893 |
|
|
|
2021-02-16 |
13G/A
|
ENVA / Enova International, Inc.
|
|
2,035,000 |
3,049,000 |
|
|
|
2021-02-16 |
13G/A
|
SRSA / Sarissa Capital Acquisition Corp - Class A
|
|
|
1,200,000 |
|
|
|
2021-02-16 |
13G/A
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
1,850,000 |
2,683,600 |
|
|
|
2021-02-16 |
13G/A
|
DRT / DIRTT Environmental Solutions Ltd.
|
|
4,700,000 |
7,465,024 |
|
|
|
2021-02-16 |
13G/A
|
88907J107 / Novus Therapeutics, Inc.
|
|
946,204 |
35,900 |
|
|
|
2021-02-16 |
13G/A
|
INSE / Inspired Entertainment, Inc.
|
|
1,995,869 |
2,163,126 |
|
|
|
2021-02-16 |
13G/A
|
LRMR / Larimar Therapeutics, Inc.
|
|
2,701,566 |
220,136 |
|
|
|
2021-02-16 |
13G/A
|
US6821631008 / On Deck Capital, Inc.
|
|
3,459,669 |
0 |
|
|
|
2021-02-16 |
13G/A
|
MNTS / Momentus Inc.
|
|
1,500,000 |
962,892 |
|
|
|
2021-02-16 |
13G/A
|
PVAC / Penn Virginia Corp.
|
|
962,875 |
720,000 |
|
|
|
2021-02-16 |
13G/A
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
1,727,700 |
216,818 |
|
|
|
2021-01-11 |
13G
|
MRNS / Marinus Pharmaceuticals, Inc.
|
|
|
1,821,149 |
|
|
|
2020-10-19 |
13G
|
MNTS / Momentus Inc.
|
|
|
1,500,000 |
|
|
|
2020-09-09 |
13G/A
|
ENVA / Enova International, Inc.
|
|
2,000,000 |
2,035,000 |
|
|
|
2020-09-08 |
13G
|
ENVA / Enova International, Inc.
|
|
|
2,000,000 |
|
|
|
2020-03-19 |
13G
|
US6821631008 / On Deck Capital, Inc.
|
|
|
3,459,669 |
|
|
|
2020-03-16 |
13G
|
PVAC / Penn Virginia Corp.
|
|
|
962,875 |
|
|
|
2020-02-19 |
13D/A
|
ONTX / Onconova Therapeutics, Inc.
|
|
100,000 |
100,000 |
|
|
|
2020-02-18 |
13D/A
|
ONTX / Onconova Therapeutics, Inc.
|
|
593,334 |
100,000 |
|
|
|
2020-02-13 |
13G/A
|
ADMP / Adamis Pharmaceuticals Corp
|
|
4,112,885 |
1,750,000 |
|
|
|
2020-02-13 |
13D/A
|
ADMP / Adamis Pharmaceuticals Corp
|
|
4,112,885 |
1,750,000 |
|
|
|
2020-02-13 |
13G
|
DRT / DIRTT Environmental Solutions Ltd.
|
|
|
4,700,000 |
|
|
|
2020-02-13 |
13G/A
|
LRMR / Larimar Therapeutics, Inc.
|
|
2,331,413 |
2,701,566 |
|
|
|
2020-02-13 |
13G/A
|
NIHD / NII Holdings, Inc.
|
|
13,163,432 |
0 |
|
|
|
2020-02-13 |
13G/A
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
1,393,700 |
1,727,700 |
|
|
|
2020-02-13 |
13G/A
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
1,610,529 |
1,850,000 |
|
|
|
2020-02-13 |
13G/A
|
GLMD / Galmed Pharmaceuticals Ltd.
|
|
1,350,000 |
800,000 |
|
|
|
2020-02-13 |
13G/A
|
SLNO / Soleno Therapeutics, Inc.
|
|
1,446,555 |
1,024,330 |
|
|
|
2020-02-13 |
13G/A
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
1,342,839 |
1,153,373 |
|
|
|
2020-02-13 |
13G/A
|
TCON / TRACON Pharmaceuticals, Inc.
|
|
2,981,250 |
258,893 |
|
|
|
2020-02-13 |
13G/A
|
TRVG / trivago N.V. - Depositary Receipt (Common Stock)
|
|
5,600,000 |
2,156,700 |
|
|
|
2020-02-13 |
13G/A
|
INSE / Inspired Entertainment, Inc.
|
|
1,994,619 |
1,995,869 |
|
|
|
2020-02-13 |
13G/A
|
88907J107 / Novus Therapeutics, Inc.
|
|
1,192,817 |
946,204 |
|
|
|
2020-02-13 |
13G/A
|
RDHL / RedHill Biopharma Ltd. - Depositary Receipt (Common Stock)
|
|
3,693,840 |
1,034,650 |
|
|
|
2020-02-13 |
13G/A
|
SLS / SELLAS Life Sciences Group, Inc.
|
|
1,275,000 |
38,000 |
|
|
|
2020-02-13 |
13G/A
|
SQBG / Sequential Brands Group Inc.
|
|
3,356,200 |
500,000 |
|
|
|
2019-09-20 |
13D/A
|
ONTX / Onconova Therapeutics, Inc.
|
|
16,503,169 |
593,334 |
|
|
|
2019-09-16 |
13G
|
LRMR / Larimar Therapeutics, Inc.
|
|
|
2,331,413 |
|
|
|
2019-08-12 |
13G
|
ADMP / Adamis Pharmaceuticals Corp
|
|
|
4,112,885 |
|
|
|
2019-07-26 |
13G
|
88907J107 / Novus Therapeutics, Inc.
|
|
|
1,192,817 |
|
|
|
2019-06-28 |
13D/A
|
MHLD / Maiden Holdings, Ltd.
|
|
7,876,964 |
7,876,964 |
|
|
|
2019-03-22 |
13D
|
MHLD / Maiden Holdings, Ltd.
|
|
|
7,876,964 |
|
|
|
2019-02-14 |
13G/A
|
NYRT / New York REIT, Inc.
|
|
850,000 |
938,730 |
|
|
|
2019-02-14 |
13G/A
|
TRVG / trivago N.V. - Depositary Receipt (Common Stock)
|
|
4,962,092 |
5,600,000 |
|
|
|
2019-02-14 |
13G/A
|
CVNA / Carvana Co.
|
|
1,138,804 |
1,860,000 |
|
|
|
2019-02-14 |
13G/A
|
RDHL / RedHill Biopharma Ltd. - Depositary Receipt (Common Stock)
|
|
2,797,686 |
3,693,840 |
|
|
|
2019-02-14 |
13G/A
|
SQBG / Sequential Brands Group Inc.
|
|
3,351,400 |
3,356,200 |
|
|
|
2019-02-14 |
13G/A
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
835,405 |
1,610,529 |
|
|
|
2019-02-14 |
13G/A
|
INSE / Inspired Entertainment, Inc.
|
|
1,332,898 |
1,994,619 |
|
|
|
2019-02-14 |
13G/A
|
CFRX / ContraFect Corp
|
|
3,867,004 |
3,530,000 |
|
|
|
2019-02-14 |
13G/A
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
1,245,000 |
1,342,839 |
|
|
|
2019-02-14 |
13G/A
|
TCON / TRACON Pharmaceuticals, Inc.
|
|
1,490,000 |
2,981,250 |
|
|
|
2019-02-14 |
13G/A
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
1,000,000 |
1,393,700 |
|
|
|
2019-02-14 |
13G/A
|
FENC / Fennec Pharmaceuticals Inc.
|
|
971,352 |
971,351 |
|
|
|
2019-02-14 |
13G/A
|
NIHD / NII Holdings, Inc.
|
|
12,671,154 |
13,163,432 |
|
|
|
2018-11-29 |
13G
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
1,245,000 |
|
|
|
2018-10-15 |
13G
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
835,405 |
|
|
|
2018-08-06 |
13G
|
RDHL / RedHill Biopharma Ltd. - Depositary Receipt (Common Stock)
|
|
1,409,037 |
2,797,686 |
|
|
|
2018-07-26 |
13G
|
NYRT / New York REIT, Inc.
|
|
|
850,000 |
|
|
|
2018-07-23 |
13G
|
SLS / SELLAS Life Sciences Group, Inc.
|
|
|
1,275,000 |
|
|
|
2018-06-22 |
13G/A
|
GLMD / Galmed Pharmaceuticals Ltd.
|
|
649,295 |
1,350,000 |
|
|
|
2018-05-01 |
13D/A
|
ONTX / Onconova Therapeutics, Inc.
|
|
4,664,934 |
16,503,169 |
|
|
|
2018-04-27 |
13G/A
|
TRVG / trivago N.V. - Depositary Receipt (Common Stock)
|
|
3,234,664 |
4,962,092 |
|
|
|
2018-03-16 |
13G
|
SLNO / Soleno Therapeutics, Inc.
|
|
|
1,446,555 |
|
|
|
2018-02-22 |
13G/A
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
1,440,000 |
1,440,000 |
|
|
|
2018-02-16 |
13D/A
|
ONTX / Onconova Therapeutics, Inc.
|
|
|
4,664,934 |
|
|
|
2018-02-16 |
13D
|
ONTX / Onconova Therapeutics, Inc.
|
|
|
4,664,934 |
|
|
|
2018-02-14 |
13G/A
|
SQBG / Sequential Brands Group Inc.
|
|
3,185,000 |
3,351,400 |
|
|
|
2018-02-14 |
13G/A
|
INSE / Inspired Entertainment, Inc.
|
|
1,340,115 |
1,332,898 |
|
|
|
2018-02-14 |
13G/A
|
TCON / TRACON Pharmaceuticals, Inc.
|
|
895,000 |
1,490,000 |
|
|
|
2018-02-14 |
13G/A
|
GEVO / Gevo, Inc.
|
|
492,503 |
0 |
|
|
|
2018-02-14 |
13G/A
|
FENC / Fennec Pharmaceuticals Inc.
|
|
787,532 |
971,352 |
|
|
|
2018-02-14 |
13G/A
|
CFRX / ContraFect Corp
|
|
3,850,000 |
3,867,004 |
|
|
|
2018-02-14 |
13G/A
|
INNL / Innocoll Holdings plc
|
|
1,600,502 |
0 |
|
|
|
2018-02-14 |
13G/A
|
CVNA / Carvana Co.
|
|
1,198,804 |
1,138,804 |
|
|
|
2018-01-22 |
13G
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
|
1,000,000 |
|
|
|
2018-01-18 |
13G
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
|
1,440,000 |
|
|
|
2018-01-18 |
13G/A
|
TRVG / trivago N.V. - Depositary Receipt (Common Stock)
|
|
2,225,000 |
3,234,664 |
|
|
|
2018-01-16 |
13G
|
RDHL / RedHill Biopharma Ltd. - Depositary Receipt (Common Stock)
|
|
|
1,409,037 |
|
|
|
2017-12-22 |
13G
|
CVNA / Carvana Co.
|
|
|
1,198,804 |
|
|
|
2017-12-22 |
13G/A
|
NIHD / NII Holdings, Inc.
|
|
5,274,515 |
12,671,154 |
|
|
|
2017-12-18 |
13G
|
GLMD / Galmed Pharmaceuticals Ltd.
|
|
|
649,295 |
|
|
|
2017-12-18 |
13G
|
TRVG / trivago N.V. - Depositary Receipt (Common Stock)
|
|
|
2,225,000 |
|
|
|
2017-12-07 |
13G
|
SQBG / Sequential Brands Group Inc.
|
|
|
3,185,000 |
|
|
|
2017-11-16 |
13G
|
INSE / Inspired Entertainment, Inc.
|
|
|
1,340,115 |
|
|
|
2017-09-28 |
13G
|
TCON / TRACON Pharmaceuticals, Inc.
|
|
|
895,000 |
|
|
|
2017-08-21 |
13G
|
NIHD / NII Holdings, Inc.
|
|
|
5,274,515 |
|
|
|
2017-07-31 |
13G
|
CFRX / ContraFect Corp
|
|
|
3,850,000 |
|
|
|
2017-04-27 |
13G
|
INNL / Innocoll Holdings plc
|
|
|
1,600,502 |
|
|
|
2017-02-14 |
13G/A
|
FENC / Fennec Pharmaceuticals Inc.
|
|
|
787,532 |
|
|
|
2017-01-11 |
13G
|
GEVO / Gevo, Inc.
|
|
88,128 |
492,503 |
|
|
|
2016-02-16 |
13G/A
|
GEVO / Gevo, Inc.
|
|
1,195,961 |
88,128 |
|
|
|
2015-11-23 |
13G
|
GEVO / Gevo, Inc.
|
|
|
1,195,961 |
|
|
|
2015-01-28 |
13G/A
|
GEVO / Gevo, Inc.
|
|
|
2,815,107 |
|
|
|
2015-01-28 |
13G/A
|
FENC / Fennec Pharmaceuticals Inc.
|
|
|
932,895 |
|
|
|
2015-01-13 |
13D/A
|
09689U102 / Body Central Corp.
|
|
|
1,285,715 |
|
|
|
2014-07-07 |
13D
|
09689U102 / Body Central Corp.
|
|
|
12,857,142 |
|
|
|
2014-04-24 |
13G/A
|
92346R100 / Veris Gold Corp
|
|
|
10,147,950 |
|
|
|
2014-04-24 |
13G/A
|
GEVO / Gevo, Inc.
|
|
|
3,750,548 |
|
|
|
2014-04-24 |
13G/A
|
FENC / Fennec Pharmaceuticals Inc.
|
|
|
4,446,801 |
|
|
|
2014-02-07 |
13G/A
|
GEVO / Gevo, Inc.
|
|
|
3,838,382 |
|
|
|
2014-02-07 |
13G/A
|
SUPN / Supernus Pharmaceuticals, Inc.
|
|
|
1,592,205 |
|
|
|
2014-02-07 |
13G/A
|
FENC / Fennec Pharmaceuticals Inc.
|
|
|
4,446,802 |
|
|
|
2014-02-07 |
13G/A
|
92346R100 / Veris Gold Corp
|
|
|
10,147,950 |
|
|
|
2014-02-07 |
13G/A
|
APTS / Preferred Apartment Communities Inc - Class A
|
|
|
555,000 |
|
|
|
2013-11-04 |
13G
|
868459AA6 / Supernus Pharmaceuticals, Inc. Bond
|
|
|
2,242,580 |
|
|
|
2013-05-31 |
13G
|
APTS / Preferred Apartment Communities Inc - Class A
|
|
|
714,285 |
|
|
|
2013-04-19 |
13G
|
92346R100 / Veris Gold Corp
|
|
|
5,800,050 |
|
|
|
2013-01-31 |
13G/A
|
GEVO / Gevo, Inc.
|
|
|
3,698,024 |
|
|
|
2013-01-31 |
13G/A
|
FURX / Furiex Pharmaceuticals, Inc.
|
|
|
150,342 |
|
|
|
2013-01-31 |
13G/A
|
04544X300 / Assisted Living Concepts Inc
|
|
|
1,321,288 |
|
|
|
2012-10-12 |
13G
|
GEVO / Gevo, Inc.
|
|
|
3,027,844 |
|
|
|
2012-08-20 |
13G
|
04544X300 / Assisted Living Concepts Inc
|
|
|
1,150,000 |
|
|
|
2012-02-13 |
13G/A
|
FENC / Fennec Pharmaceuticals Inc.
|
|
|
2,162,469 |
|
|
|
2012-02-13 |
13G/A
|
FURX / Furiex Pharmaceuticals, Inc.
|
|
|
557,527 |
|
|
|
2012-01-13 |
13D/A
|
VXRT / Vaxart, Inc.
|
|
|
1,872,682 |
|
|
|